PARP Inhibitors in Ovarian Cancer Treatment

被引:9
|
作者
Spriggs, David R. [1 ]
Longo, Dan L. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, New York, NY 10021 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 375卷 / 22期
关键词
RECOMBINATION;
D O I
10.1056/NEJMe1612843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:2197 / 2198
页数:2
相关论文
共 50 条
  • [1] PARP Inhibitors for the Treatment of Ovarian Cancer
    Cortesi, Laura
    Toss, Angela
    Cucinotto, Iole
    CURRENT CANCER DRUG TARGETS, 2018, 18 (09) : 877 - 893
  • [2] PARP inhibitors in the treatment of ovarian cancer
    Zeimet, Alain G.
    Wieser, Verena
    Knoll, Katharina
    Reimer, Daniel
    Marth, Christian
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (02) : 198 - 201
  • [3] PARP inhibitors in the treatment of ovarian cancer
    Alain G. Zeimet
    Verena Wieser
    Katharina Knoll
    Daniel Reimer
    Christian Marth
    memo - Magazine of European Medical Oncology, 2020, 13 : 198 - 201
  • [4] PARP inhibitors in the treatment of ovarian cancer: a review
    Washington, Christina R.
    Moore, Kathleen N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 1 - 6
  • [5] PARP inhibitors for targeted treatment in ovarian cancer
    Dizon, Don S.
    LANCET, 2017, 390 (10106): : 1929 - 1930
  • [6] Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer
    Kurnit, Katherine C.
    Coleman, Robert L.
    Westin, Shannon N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (12)
  • [7] What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
    Joyce F. Liu
    Ursula A. Matulonis
    Current Oncology Reports, 2016, 18
  • [8] Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer
    Katherine C. Kurnit
    Robert L. Coleman
    Shannon N. Westin
    Current Treatment Options in Oncology, 2018, 19
  • [9] PARP-INHIBITORS ROLE IN THE TREATMENT OF OVARIAN CANCER
    Mahon, Lauren
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [10] Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors
    Aliyuda, Fine
    Moschetta, Michele
    Ghose, Aruni
    Rallis, Kathrine Sofia
    Sheriff, Matin
    Sanchez, Elisabet
    Rassy, Elie
    Boussios, Stergios
    CURRENT CANCER DRUG TARGETS, 2023, 23 (06) : 433 - 446